BFM
AIFF

Boothbay Fund Management’s Firefly Neuroscience AIFF Stock Holding History

Boothbay Fund Management’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
+178,750
New +$311K ﹤0.01% 1903

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Boothbay Fund Management's AIFF Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Firefly Neuroscience (AIFF) in Q2 2026: 178,750 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #1903 among its holdings.

22 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Boothbay Fund Management held 178,750 shares of Firefly Neuroscience worth $216K as of Q2 2026.
  • Firefly Neuroscience was a new Boothbay Fund Management position in Q2 2026.
  • Firefly Neuroscience made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1903 holding.
  • 22 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.